United States Breast Imaging Market Overview
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Growth Rate: 7.00% (2024-2032)
The United States breast imaging market is experiencing significant growth, driven by advancements in imaging technology, rising breast cancer awareness, and increasing demand for early detection and diagnostic solutions. According to the latest report by IMARC Group, The United States breast imaging market size is projected to exhibit a growth rate (CAGR) of 7.00% during 2024-2032.
United States Breast Imaging Industry Trends and Drivers:
The rise in breast cancer cases and the push for early detection are key drivers of the U.S. breast imaging market. New mammography techniques, like 3D tomosynthesis, boost diagnostic accuracy and lower false positives. More women are getting regular screenings due to increased awareness about preventive healthcare and insurance coverage mandates. Also, AI tools help radiologists spot issues sooner, improving treatment results. Government efforts, such as breast cancer awareness campaigns, are increasing screening rates, especially in underserved communities.
Another key trend is using contrast-enhanced mammography and automated breast ultrasound for high-risk patients. Portable and handheld imaging devices are improving access in rural and mobile clinics. Research investments in new imaging biomarkers are leading to more personalized diagnostics. However, high equipment costs and reimbursement issues still pose challenges. Yet, technological advances may make these tools more affordable over time. Additionally, tele-radiology is streamlining image analysis, allowing for quicker and more efficient diagnoses.
Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-breast-imaging-market/requestsample
United States Breast Imaging Industry Segmentation:
The report has segmented the market into the following categories:
Technology Insights:
- Ionizing Breast Imaging
- Mammography
- Positron Emission Tomography-Computed Tomography
- Molecular Breast Imaging
- Positron Emission Mammography
- Cone-Beam Computed Tomography
- Non-Ionizing Breast Imaging
- Breast Ultrasound
- Breast MRI
- Automated Whole-Breast Ultrasound
- Breast Thermography
- Electric Impedance Tomography
- Optical Imaging
End User Insights:
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
- Aurora Healthcare US Corp.
- Carestream Health Inc.
- FUJIFILM Holdings Corporation
- GE HealthCare Technologies Inc.
- Philips Healthcare
- Siemens Medical Solutions USA Inc. (Siemens AG)
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
